US Patent 10493140 Anti-ICOS agonist antibodies and uses thereof
Patent 10493140 was granted and assigned to Bristol-Myers Squibb on December, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10493140 Anti-ICOS agonist antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.